Benign familial neonatal convulsions: Always benign?

BACKGROUND Benign familial neonatal convulsions (BFNC) is a rare autosomal dominant seizure disorder usually described to be characterized by a benign course, spontaneous remission and normal psychomotor development. The latter statement had come under consideration when a few case reports of families with less than favorable outcomes were published. METHODS Since 1998 a total of 112 families suspected to have BFNC have been referred to our lab for genetic testing. Within this sample we identified private KCNQ2 mutations in 17 BFNC families. For 10 of those 17 families follow up information about the psychomotor development and the outcome were available. RESULTS In 4 (40%) of the 10 families at least 1 affected individual showed delayed psychomotor development or mental retardation. Three of the four mutations were familial, while the fourth mutation was de novo. Mutations associated with an unfavorable outcome tended to be located within the functionally critical S5/S6 regions of the KCNQ2 gene. CONCLUSIONS Our data raise the question if BFNC can indeed be described as a benign disorder, and which are the genetic and/or environmental factors that influence the outcome.

[1]  H. Tsutsumi,et al.  Classification of familial neonatal convulsions , 1994, The Lancet.

[2]  Samuel F. Berkovic,et al.  Febrile seizures and generalized epilepsy associated with a mutation in the Na+-channel ß1 subunit gene SCN1B , 1998, Nature Genetics.

[3]  Yukitoshi Takahashi,et al.  Mutations of sodium channel alpha subunit type 1 (SCN1A) in intractable childhood epilepsies with frequent generalized tonic-clonic seizures. , 2003, Brain : a journal of neurology.

[4]  Stéphanie Baulac,et al.  Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2 , 2000, Nature Genetics.

[5]  Karin Dedek,et al.  Myokymia and neonatal epilepsy caused by a mutation in the voltage sensor of the KCNQ2 K+ channel , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[6]  M. Leppert,et al.  Seizure characteristics in chromosome 20 benign familial neonatal convulsions , 1993, Neurology.

[7]  M. Leppert,et al.  KCNQ2 and KCNQ3 potassium channel genes in benign familial neonatal convulsions: expansion of the functional and mutation spectrum. , 2003, Brain : a journal of neurology.

[8]  O. Steinlein,et al.  A KCNQ2 splice site mutation causing benign neonatal convulsions in a Scottish family. , 2000, Neuropediatrics.

[9]  I. Bjerre,et al.  BENIGN FAMILIAL NEONATAL CONVULSIONS , 1968, Acta paediatrica Scandinavica.

[10]  Karin Dedek,et al.  Neonatal convulsions and epileptic encephalopathy in an Italian family with a missense mutation in the fifth transmembrane region of KCNQ2 , 2003, Epilepsy Research.

[11]  B. L. Hajnal,et al.  Neonatal seizures with tonic clonic sequences and poor developmental outcome , 2005, Epilepsy Research.

[12]  N. Bresolin,et al.  A novel mutation in KCNQ2 associated with BFNC, drug resistant epilepsy, and mental retardation , 2004, Neurology.

[13]  Steven Petrou,et al.  SCN1A mutations and epilepsy , 2005, Human mutation.

[14]  Robin J. Leach,et al.  A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family , 1998, Nature Genetics.

[15]  Berten Ceulemans,et al.  De novo SCN1A mutations are a major cause of severe myoclonic epilepsy of infancy , 2003, Human mutation.

[16]  Douglas C. Wallace,et al.  Radicals r'aging , 1998, Nature Genetics.

[17]  S. Berkovic,et al.  A potassium channel mutation in neonatal human epilepsy. , 1998, Science.

[18]  Mark Leppert,et al.  A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns , 1998, Nature Genetics.

[19]  B S Brown,et al.  KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel. , 1998, Science.